Switching to biosimilars in the treatment of rheumatic diseases. [electronic resource]
- Expert review of clinical immunology 07 2018
- 557-571 p. digital
Publication Type: Journal Article; Review
1744-8409
10.1080/1744666X.2018.1490178 doi
Animals Antirheumatic Agents--therapeutic use Biosimilar Pharmaceuticals--therapeutic use Drug Approval Drug Substitution Evidence-Based Medicine Expert Testimony Humans Randomized Controlled Trials as Topic Rheumatic Diseases--drug therapy